Overall, comorbidities were collected for 213 new prostate cancer visits to the urology clinic through an online survey, before the clinical encounter. The frequency distributions of comorbidities as reported by patients before physician review was compared to those documented by physicians for a sample of 298 consecutive patients presenting to the same urology clinic before the survey began.
The results demonstrated that patient were extremely satisfied with the survey. Comorbidities and life expectancy estimates were highly comparable between the two groups. A few comorbidity categories were reported in higher frequency in the patient-reported group compared to the physician-documented group. These included: cardiovascular (25% vs. 20%), vascular-related (8.5% vs. 4.4%), neurologic (7.5% vs. 1.7%), gastrointestinal (30% vs. 25%), musculoskeletal comorbidities (30% vs. 21%), as well as other cancers (30% vs. 12%). In contrast, genitourinary comorbidities, including lower urinary tract symptoms and erectile dysfunction were more commonly reported in the physician group (68% vs. 53%).
In summary, in this elegant presentation it was shown that patients completing a novel online web-based tool, focusing on their medical history, provide relatively accurate and complete information, even before physician review.
Presented by: Katherine Fleshner, London, Ontario, Canada
Written By: Hanan Goldberg, MD, Urologic Oncology Fellow (SUO), University of Toronto, Princess Margaret Cancer Centre
at the 2017 AUA Annual Meeting - May 12 - 16, 2017 – Boston, Massachusetts, USA